Wolverine Trading
MACK

Wolverine Trading’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Wolverine Trading’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,600
Closed -$91K – 6255
2022
Q1 		$91K Buy
+14,600
New +$82K ﹤0.01% 4865
2021
Q1 		– Sell
-14,100
Closed -$97K – 6655
2020
Q4 		$97K Buy
+14,100
New +$69.5K ﹤0.01% 4474
2020
Q1 		– Sell
-11,700
Closed -$37K – 5710
2019
Q4 		$37K Buy
+11,700
New +$46.9K ﹤0.01% 4514
2019
Q3 		– Sell
-12,964
Closed -$62K – 5397
2019
Q2 		$62K Buy
+12,964
New +$61.4K ﹤0.01% 4147
2017
Q3 		– Sell
-4,792
Closed -$49K – 5515
2017
Q2 		$49K Sell
4,792
-4,346
-48% -$88.8K ﹤0.01% 4065
2017
Q1 		$220K Sell
9,138
-255
-3% -$6.38K ﹤0.01% 3408
2016
Q4 		$302K Buy
9,393
+1,843
+24% +$78.6K ﹤0.01% 3259
2016
Q3 		$372K Buy
7,550
+5,033
+200% +$209K ﹤0.01% 2944
2016
Q2 		$111K Buy
+2,517
New +$137K ﹤0.01% 3591

Other funds holding MACK

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wolverine Trading's MACK Position: Q2 2021 in Review

Wolverine Trading sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2021, closing a stake of 10,124 shares — an estimated $66.8K sold.

Wolverine Trading first reported a position in MACK in Q4 2016 and held it in 5 quarters. The position peaked at $91K in Q2 2018. 43 funds tracked by Wall St. Rank hold MACK as of Q2 2021.

  • Wolverine Trading reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 10,124 Merrimack Pharmaceuticals, Inc. shares in Q2 2021, an estimated $66.8K.
  • Wolverine Trading first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
  • Wolverine Trading's Merrimack Pharmaceuticals, Inc. position peaked at $91K in Q2 2018.
  • 43 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.